Market Research Logo

Conference Documentation: Pharmaceutical Microbiology

Conference Documentation: Pharmaceutical Microbiology

This event is about the developments in the field of pharmaceutical Microbiology. Pharmaceutical microbiology is crucial to the manufacture and production of drugs, biologics and devices. Without a strong understanding of the process from case studies and learning from mistakes it can be incredibly costly.

Set to take place in Central London on the 20th-21st January 2016 the 5th annual pharmaceutical biology will once again be bringing together industry leaders and key figures in the field to discuss and develop a greater understanding of key issues and regulations.

Join us to explore developments in mechanisms to detect pathogens, case studies on contaminations, endotoxin detection and LER, case studies in pharmaceutical microbiology, regulatory changes and VBNC's.


Day 1
8:30
Registration & Coffee
9:00
Chairman's Opening Remarks
Olivier Chancel, Sterility and Aseptic Process Assurance Expert , Merial Sas
9:10
Particle deposition monitoring the missing link in contamination control
Koos Agricola, Contamination Control Specialist, International Confederation of Contamination Control Societies
9:50
Use of RMM in bacteriology lab: Application and Implementation
Thierry Bonnevay, Microbiology Plateform Head, Sanofi-Aventis
10:30
Morning Coffee
11:00
Advanced light microscopy to detect VBNC pathogens and biofilms
Bill Keevil, Scientific Advisor to the House of Commons Select Committee on Science & Technology, Head of the Microbiology Group and Director of the Environmental Healthcare Unit. University of Southampton, UK, University of Southampton
11:40
DNA-sequencing based methods: How will they shape of routine microbial testing in the future?
Adrianne Klijn, Group leader Microbiological and Molecular Analytics, Nestle Research Center
12:20
Networking Lunch
13:50
Operating a bioburden control facility within the vaccine industry
Sabina Lancaster, Senior Manager Sterility assurance Global QA, GSK
14:30
Endotoxin Testing of Biologics - New Insights
Holger Grallert, Vice President, Hyglos GmbH
15:10
Afternoon Tea
15:40
Endotoxin Test Concerns of Biologics
Kevin Williams, Senior Scientist, Lonza Incorporated
16:20
Cleanrooms to Clinic – managing microbiology of stem cell manufacture
Thomas Caws, QC Associate, ReNeuron Group plc
17:00
Chairman’s Closing Remarks and Close of Day One
Day 2
8:30
Registration & Coffee
9:00
Chairman's Opening Remarks
Francesco Boschi, Microbiological Services Manager, GSK Manufacturing S.p.A.
9:10
Sterility case studies and management perspectives
Olivier Chancel, Sterility and Aseptic Process Assurance Expert , Merial Sas
9:50
Risked based contamination control and environmental monitoring in sterile product manufacturing
James Drinkwater, Chairman of PHSS Pharmaceutical & Healthcare Sciences Society , PHSS
10:30
Morning Coffee
11:00
Assessment Methods for Accurate Determination of Microbial Contamination During Cleanroom Manufacture
Tim Eaton, Sterile Manufacturing Specialist, Astrazeneca
11:40
Current Practices in Disinfectant Validation and Starting Up a Cleanroom after a Worst Case Event:
Jim Polarine, Technical Service Manager, STERIS Corporation
12:20
Networking Lunch
13:40
Afternoon Chair Opening Remarks
Salome Giao, Reseach scientist, Dyson Technology Ltd
13:50
VBNC – How Culturable is Culturable? Detection, Non-Detection and all Points In-Between
Colin Fricker, Adjunct Professor of Environmental Studies, Queen’s University, Kingston, Ontario
14:30
Bioburden test of bulk solutions before sterilizing filtration: current practices and expectations
Francesco Boschi, Microbiological Services Manager, GSK Manufacturing S.p.A.
15:10
Afternoon Tea
15:40
Risk analysis and mitigation of the analysis process of sterility testing in an isolator environment
Hans Noordergraaf, Microbiologist, Abbott Biologicals B V
16:20
Controlling and monitoring contamination in water for pharmaceutical use (WPU)
Robert Neri , Water for Pharmaceutical Use Referent , Sanofi Pharma
17:00
The viable but non-Cultivable (VBNC) state of pathogens: a myth or reality?
Salome Giao, Reseach scientist, Dyson Technology Ltd
17:40
Chairman’s Closing Remarks and Close of Day Two

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report